Trading Ideas Mesoblast Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:26 2026-04-10 am EDT			5-day change	1st Jan Change
2.120 ^AUD	+4.43%		-0.47%	-22.06%

Apr. 10	Mesoblast Gets US FDA Clearance to Proceed to Registrational Trial for Ryoncil in Duchenne Muscular Dystrophy	MT
Apr. 09	Mesoblast's Fiscal 2026 Net Revenue Projected to be Up to $120 Million, Jefferies Says	MT

No results for this search

Mesoblast Leads Global Regenerative Therapy Expansion

February 13, 2026 at 04:51 am EST